SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Money Maker (MM) who wrote (6517)7/6/1998 1:27:00 PM
From: Money Maker (MM)  Read Replies (1) of 8798
 
BICO, news out on yahoo. Check it out.
biz.yahoo.com

Monday July 6, 12:52 pm Eastern Time

Company Press Release

SOURCE: Biocontrol Technology, Inc.

Biocontrol Preparing to Ship Diasensor 1000 Recently
Approved for the European Market

PITTSBURGH, July 6 /PRNewswire/ -- Biocontrol Technology, Inc. (Nasdaq: BICO - news)
announced today that it is preparing to ship the Diasensor(R)1000 noninvasive glucose sensor to the
United Kingdom. As Biocontrol announced on Thursday, July 2, the Company was awarded
approval to apply the CE Mark to the Diasensor. The CE Mark is recognized worldwide and allows
marketing of product in almost every country of the world except the US.

The Company's European distributor, EuroSurgical, Ltd., has been informed of the approval and
plans are being implemented by the two companies to begin a marketing campaign for the sensor in
the UK.

Biocontrol President, David L. Purdy, said, ''The company expects quick orders from EuroSurgical
and will make shipment within the week from immediately available inventory.''

The application of the CE Mark signifies that the device meets certain quality conformance standards
and safety requirements in accordance with the Medical Device Directive established by the EU and
that performance and efficacy was proven by data collected in the company's clinical trials. This level
of product qualification became mandatory on June 14, 1998 for shipment of medical devices into
the EU.

Biocontrol Technology, Inc. (www.bico.com) has its corporate offices in Pittsburgh, PA and is
involved in the development and manufacture of biomedical devices and environmental products.

This press release contains statements of a forward looking nature. Shareholders and potential
investors are cautioned that such statements are predictions and actual events or results may vary
significantly.

SOURCE: Biocontrol Technology, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext